What are Targeted Therapies Against Growth Factors?
Understanding the role of growth factors in cancer has led to the development of targeted therapies. Drugs like trastuzumab (Herceptin) target HER2 receptors, while bevacizumab (Avastin) inhibits VEGF. These therapies aim to block the growth factor signaling pathways, thereby hindering tumor growth and spread.